⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ricolinostat

Every month we try and update this database with for ricolinostat cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple MyelomaNCT02189343
Multiple Myelom...
ACY-1215 in com...
18 Years - Celgene
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological CancerNCT02661815
Ovarian Cancer
Fallopian Tube ...
Primary Periton...
Paclitaxel
Ricolinostat
Bevacizumab
18 Years - Dana-Farber Cancer Institute
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic CholangiocarcinomaNCT02856568
Non-Resectable ...
Recurrent Chola...
Stage III Extra...
Stage III Intra...
Stage IIIA Hila...
Stage IIIB Hila...
Stage IVA Extra...
Stage IVA Hilar...
Stage IVA Intra...
Stage IVB Extra...
Stage IVB Hilar...
Stage IVB Intra...
Unresectable Ex...
Cisplatin
Gemcitabine Hyd...
Laboratory Biom...
Pharmacological...
Ricolinostat
18 Years - Mayo Clinic
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple MyelomaNCT02189343
Multiple Myelom...
ACY-1215 in com...
18 Years - Celgene
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: